Patent details

EP2799070 Title: EFFECT POTENTIATOR FOR ANTITUMOR AGENTS

Basic Information

Publication number:
EP2799070
PCT Application Number:
JP2012083794
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP128634763
PCT Publication Number:
WO2013100014
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
EFFECT POTENTIATOR FOR ANTITUMOR AGENTS
French Title of Invention:
POTENTIALISATEUR D'EFFET POUR DES AGENTS ANTI-TUMORAUX
German Title of Invention:
WIRKUNGSVERSTÄRKER FÜR ANTITUMORMITTEL
SPC Number:

Dates

Filing date:
27/12/2012
Grant date:
13/02/2019
EP Publication Date:
05/11/2014
PCT Publication Date:
04/07/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/02/2019
EP B1 Publication Date:
13/02/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/12/2019
Expiration date:
27/12/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/02/2019
 
 

Name:
Taiho Pharmaceutical Co., Ltd.
Address:
1-27 Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444, Japan (JP)

Inventor

1

Name:
KATO, Masanori
Address:
Japan (JP)

2

Name:
FUJITA, Hidenori
Address:
Japan (JP)

Priority

Priority Number:
2011290125
Priority Date:
28/12/2011
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 31/337; A61K 31/4412; A61K 31/47; A61K 31/4745; A61K 31/513; A61K 31/517; A61K 31/53; A61K 31/7068; A61K 45/00; A61P 35/00;

Publication

European Patent Bulletin

Issue number:
201907
Publication date:
13/02/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages